These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. Lazar M, Stănescu A, Penedos AR, Pistol A. Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098 [Abstract] [Full Text] [Related]
6. MMR vaccination and disease elimination: the Finnish experience. Davidkin I, Kontio M, Paunio M, Peltola H. Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347 [Abstract] [Full Text] [Related]
7. Childhood vaccination coverage of hepatitis A, measles, mumps and rubella, and varicella: temporal trend analysis in Minas Gerais, Brazil. Oliveira GCCF, Rodrigues RN, Silva MCD, Nascimento GLMD, Lanza FM, Gusmão JD, Oliveira VC, Guimarães EAA. Rev Bras Epidemiol; 2022 Sep; 25():e220010. PubMed ID: 35544837 [Abstract] [Full Text] [Related]
12. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study]. He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP. Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468 [Abstract] [Full Text] [Related]
13. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR, Choe YJ, Go UY, Kim YI, Lee JK. Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654 [Abstract] [Full Text] [Related]
14. Surveillance and vaccination coverage of measles and rubella in Northern Italy. Amendola A, Bubba L, Piralla A, Binda S, Zanetti A, Pariani E, Ranghiero A, Premoli M, Pellegrinelli L, Coppola L, Gramegna M, Baldanti F, Zanetti A. Hum Vaccin Immunother; 2015 May 31; 11(1):206-13. PubMed ID: 25483537 [Abstract] [Full Text] [Related]
16. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014. Chang C, Mo X, Hu P, Liang W, Ma H, An Z, Liu J, Zheng H. Vaccine; 2015 Jun 22; 33(28):3223-7. PubMed ID: 25989448 [Abstract] [Full Text] [Related]
19. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children. Lee CY, Tang RB, Huang FY, Tang H, Huang LM, Bock HL. Int J Infect Dis; 2002 Sep 22; 6(3):202-9. PubMed ID: 12718836 [Abstract] [Full Text] [Related]
20. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations. Hyle EP, Rao SR, Jentes ES, Parker Fiebelkorn A, Hagmann SHF, Taylor Walker A, Walensky RP, Ryan ET, LaRocque RC. Ann Intern Med; 2017 Jul 18; 167(2):77-84. PubMed ID: 28505632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]